To: | Hi-Tech Pharmaceuticals, Inc. (ghillyer@hillyerlegal.com) |
Subject: | U.S. Trademark Application Serial No. 88291503 - BETAGEN - N/A |
Sent: | May 14, 2020 07:25:56 PM |
Sent As: | ecom118@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88291503
Mark: BETAGEN
|
|
Correspondence Address: |
|
Applicant: Hi-Tech Pharmaceuticals, Inc.
|
|
Reference/Docket No. N/A
Correspondence Email Address: |
|
SUSPENSION INQUIRY
Response Required
The USPTO must receive applicant’s response to this inquiry letter within six months of the issue date below or the application will be abandoned. Respond using the Trademark Electronic Application System (TEAS). A link to the appropriate TEAS response form appears at the end of this Office action.
Issue date: May 14, 2020
The trademark examining attorney is issuing this inquiry letter to determine whether the application should continue to be suspended.
Status required regarding legal proceeding(s) involving the applied-for mark. The application was previously suspended until a legal proceeding(s) related to the registrability of applicant’s mark terminated. TMEP §§716.02(d), 716.05.
Cancellation No(s). 92072368
How to respond. Applicant’s response to this inquiry should include one of the following:
(1) A statement that the proceeding(s) is still pending,
(2) A statement that the proceeding(s) has been suspended (including an explanation of why), or
(3) A statement that the proceeding(s) has been terminated (including a copy of any final decision or relevant agreement).
See TMEP §716.05.
Click to file a response to this suspension inquiry.
Once the reason for suspension has been resolved, the examining attorney will remove this application from suspension and resume examination.
The Section 2(d) refusal is continued and maintained.
RESPONSE:
The USPTO does not accept emails as responses to Office actions; however, emails can be used for informal communications and are included in the application record. See 37 C.F.R. §§2.62(c), 2.191; TMEP §§304.01-.02, 709.04-.05.
Trademark Examining Attorney
Law Office 118
571-272-9291
marlene.bell@uspto.gov (for informal inquiries)
RESPONSE GUIDANCE